Phase II Multicenter Clinical Trial: Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries

Principal Investigator: Micaela Hernberg
HUS Comprehensive Cancer Center

Link to the ClinicalTrials.gov website